🇺🇸 FDA
Patent

US 10342822

Method of producing physiological and therapeutic levels of nitric oxide through an oral delivery system

granted A61KA61K31/195A61K31/198

Quick answer

US patent 10342822 (Method of producing physiological and therapeutic levels of nitric oxide through an oral delivery system) held by The Board of Regents of the University of Texas System expires Mon Jul 04 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Jul 09 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 04 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K31/195, A61K31/198, A61K31/375, A61K31/714